Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Acupuncture and CHM Group:Acupuncture and Chinese herbal medicine
CHM Group:Chinese herbal medicine
Sponsors
The Affiliated Hospital to Changchun University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for patients with Covid 19 in the "Covid 19 Pneumonia Diagnosis and Treatment Program (Trial Version 9)"; 2. The clinical classification is mild and common; 3. The patient's aged >= 18 years.
Exclusion criteria
Exclusion criteria: 1. Patients who have used similar proprietary Chinese medicines before enrollment; 2. Patients with immunodeficiency diseases or used immunosuppressive agents or glucocorticoids within the past 3 months; 3. Women preparing for pregnancy, pregnant and lactating women; 4. Allergic constitution patients (referring to those allergic to two or more drugs or foods or to the known ingredients of the drug in this trial); 5. Mental patients, or patients without self-awareness. 5. Not suitable to participate in clinical trials judged by the investigator; 6. Patients not suitable to participate in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms cure rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Severe symptom conversion rate;Fever reduction time;The disappearance time and rate of single symptom;Haspitalization time;Clinical symptoms recovery time;COVID 19 negative time; | — |
Countries
China
Contacts
Public ContactWang Hongfeng
Outcome results
None listed